Research & Development: Page 70
-
PharmaVoice Team/PharmaVoice
A New World of Information Management and Collaboration
SharePoint has been adopted by more than 17,000 companies, and it has become Microsoft’s fastest-growing server product ever. There is good reason for this exponential growth — people across diverse industries find that it improves productivity and takes the knowledge worker to a new level of rea...
By PharmaVoice Team • June 4, 2010 -
PharmaVoice Team/PharmaVoice
A Prescription for R&D Refills
According to the Outlook 2010 report from the Tufts Center for the Study of Drug Development (CSDD), worldwide sales for all drugs coming off patent from 2009 through 2012 will exceed $88 billion. Drug developers and the U.S. Food and Drug Administration have worked hard to speed up the drug-deve...
By PharmaVoice Team • June 4, 2010 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Supplier Showcase
BioClinica 826 Newtown-Yardley Rd. Newtown, PA 18940 Phone: 800-392-7456 Fax: 267-757-3010 www.bioclinica.com Discover the Power of a New Combination BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceut...
By PharmaVoice Team • June 4, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Social media — Facebook, LinkedIn, etc. — have infiltrated every aspect of our life, so it should be no surprise that these virtual connectors are changing the clinical trial arena. Recruiting patients for clinical trials, and retaining them once they’ve entered those studies, remain two of the t...
By PharmaVoice Team • June 4, 2010 -
PharmaVoice Team/PharmaVoice
ACRP 2010 Global Conference & Exhibition Wrap Up
The Association of Clinical Research Professionals (ACRP) remains steadfast in its mission to provide value and excellence to conference participants against a backdrop of continued economic and regulatory challenges to individuals and businesses. This year’s conference featured 55 sessions and 2...
By PharmaVoice Team • May 27, 2010 -
PharmaVoice Team/PharmaVoice
Adaptive by Design
Adaptive trial designs have the potential to speed development and reduce overall costs — that is, if sponsors invest in up-front planning and can implement these designs correctly. Interest in adaptive designs has risen in recent years. These types of studies involve a broad class of methods and...
By Denise Myshko • May 25, 2010 -
PharmaVoice Team/PharmaVoice
View on Diversity in Clinical Trials
Rapidly changing demographics are shifting the texture and fabric of American society. So-called niche markets have become “minority-majority" markets. Current healthcare reform that is focusing on better outcomes will only place more pressure on study sponsors to demonstrate to regulators that t...
By Kathleen B. Drennan • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Dr. Nancy Simonian: One for All
There’s no place for the arch ego in today’s most progressive biotechnology companies or for that matter, at pharmaceutical companies. Rather, scientific leaders such as Nancy Simonian, M.D., are leading the charge toward collaborative ingenuity. Teamwork is very much Dr. Simonian’s mantra. Indee...
By Kim Ribbink • May 24, 2010 -
PharmaVoice Team/PharmaVoice
The Power of the Cloud
When Dave Powers, senior systems engineer, research and development IT at Eli Lilly and Company, talks about the advantages of cloud computing in the life-sciences industry, he gets pretty excited — as do others who have experienced first hand the benefits of the cloud. According to our thought l...
By Robin Robinson • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Mixed Media: The Best Ways to Reach Physicians in 2010
When considering how to successfully communicate with each physician, it is vital to consider individual physicians, their specialty, their current use of technology, their comfort level for learning new technologies, and their personal preferences for receiving information, says Cherie Hicks, pr...
By Robin Robinson • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Roger POMERANTZ Merck Appoints Head of Infectious Diseases Merck has named Roger Pomerantz, M.D., senior VP of Merck Research Laboratories (MRL) and infectious diseases franchise head. Dr. Pomerantz spent the last five years at Johnson & Johnson, where he most recently...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: AAPS Relaunches Online Career Center QuestaWeb Adds to Global Trade Management Suite SAS Releases Social Media Enterprise Solution Web Site Provides PwC Health Reform Insights Sidebar: E-upgrades and enhancements...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
What's New
SciQuest has launched the Procurement Business Assessment, a service that enables life-sciences companies to uncover cost-saving opportunities in their procurement operations. Procurement professionals often lack the resources and time to conduct the deep analysis of purchasing processes, systems...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Raise Your Voice
A personal journey Many of you are no doubt in the midst of data locks, publication deadlines, protocol designs, audits, IRB meetings, accreditation, investigator meetings, or the myriad of events that make up each of our days. If you are reading this letter, we likely met as clinical research co...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Electronic Records: Beneficial to All, But At a Price
The next five years will represent significant growth toward the implementation of electronic medical records (EMRs) in both hospitals and physician offices. Several factors are driving this new momentum, including the recent release of Notice for Proposed Rulemaking on the electronic health rec...
By Robin Robinson • April 28, 2010 -
PharmaVoice Team/PharmaVoice
Getting the Most From Distance Learning: Mistakes to Avoid
It’s no secret that the use of distance learning is on the rise. As the economy remains shaky and budgets remain tight, pharmaceutical company training departments are working diligently to squeeze every drop of value from each dollar they spend. Training teams know that distance learning can hel...
By PharmaVoice Team • April 28, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Kristin PECK Pfizer Names Head of Business Development Global healthcare company Pfizer has named Kristin Peck to succeed the retiring William Ringo as senior VP of worldwide business development, strategy, and innovation. Ms. Peck joined Pfizer’s strategic planning organizat...
By PharmaVoice Team • April 28, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Most Doctors Prefer CME Promotion by E-mail Pharma Advised to Focus Social Media Efforts on Education Pharma Ramps Up Regulatory Affairs Delivering Articulate Message Key to Managed Markets Access Sidebar: Q. Which of...
By PharmaVoice Team • April 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: BioClinica Launches System for Clinical-Trial Supply Planning New Quintiles Tool Accelerates Trial Recruitment Sidus Group Adds Life-Sciences Hosting Solution Paragon, NextDocs Collaborate on Clinical Optimizat...
By PharmaVoice Team • April 28, 2010 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: TGaS Model Helps Solve Managed Markets Staffing Dilemma Razorfish Launches Independent, Dedicated Health Division FDA, NIH Collaborate to Speed Release of Medical Innovations Sidebar: On The Shelves PSKW Adds Loyalty Relat...
By PharmaVoice Team • April 28, 2010 -
PharmaVoice Team/PharmaVoice
Case Study: EpiCept
Named Patient Programs Provide Pre-Launch Access to Drugs The dire outlook facing AML patients motivated a company to provide its drug in advance of the commercial launch. Jack V. Talley President and CEO, EpiCept EpiCept is a specialty pharmaceutical company that focuses on fulfilling unmet med...
By Jack V. Talley President and CEO • April 28, 2010 -
PharmaVoice Team/PharmaVoice
UpFront
Market Report U.S. Prescription Sales Grow U.S. sales of ethical pharmaceuticals and insulins through retail and non-retail channels grew 5.1% in 2009, reaching $300.3 billion, compared with growth of 1.8% in 2008. While the 32 innovative products launched last year brought important new treatm...
By PharmaVoice Team • April 28, 2010 -
PharmaVoice Team/PharmaVoice
Table of Contents
10 Molecule to Market The drug development process from lead generation to patent expiration is complex, fraught with risk, and extremely time and cost intensive. 16 Drug Discovery Pharmaceutical companies are using state-of-the-art technologies to understand the basis of disease as a way to brin...
By PharmaVoice Team • April 5, 2010 -
PharmaVoice Team/PharmaVoice
Contents
4 Ap r i l 201 0 Pharm aVOICE 34 James Sapirstein: Steering a Winning Course Managing a biotech company through the myriad obstacles companies face is difficult at the best of times; today it is much more taxing. James Sapirstein is proving that he has what it takes to put Tobira Therapeutics on ...
By PharmaVoice Team • March 23, 2010 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: IRBs
In accordance with federal regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This review serves an important role in the protection of the rights and welfare of human research subjects. According to the Consortium of Independe...
By PharmaVoice Team • March 23, 2010
Previous
